Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease.

MLA

Wu, Guangyu, et al. “Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease.” Scientific Reports, vol. 7, no. 1, July 2017, p. 5095. EBSCOhost, https://doi.org/10.1038/s41598-017-05257-5.

APA

Wu, G., Li, H., Fang, Q., Zhang, J., Zhang, M., Zhang, L., Wu, L., Hou, X., Lu, J., Bao, Y., & Jia, W. (2017). Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease. Scientific Reports, 7(1), 5095. https://doi.org/10.1038/s41598-017-05257-5

Chicago

Wu, Guangyu, Huating Li, Qichen Fang, Jing Zhang, Mingliang Zhang, Lei Zhang, Liang Wu, et al. 2017. “Complementary Role of Fibroblast Growth Factor 21 and Cytokeratin 18 in Monitoring the Different Stages of Nonalcoholic Fatty Liver Disease.” Scientific Reports 7 (1): 5095. doi:10.1038/s41598-017-05257-5.